Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.66%
#2 Pons Pons +41.97%
#3 Mubarak Mubarak +29.77%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.50%
#5 Starpower Starpower +28.29%
#6 TENDIES TENDIES +22.88%
#7 SkyAI SkyAI +21.17%
#8 StonkBroker StonkBroker +19.76%
#9 Decred Decred +19.75%
#10 PondCoin PondCoin +18.22%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Rangering i aksjer #29362
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Aksjekurs
$0.365
Sist synkronisert: 2025-08-01
Markedsverdi
$21.54M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Elevation Oncology, Inc. (ELEV)

Kategori

Healthcare
Aksjeprishistorikk for Elevation Oncology, Inc. (ELEV)
Høyeste sluttskurs: $0.37 den 2025-08-01

Laveste sluttskurs: $12.36 den 2021-06-01
Aksjeprishistorikk for Elevation Oncology, Inc. fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2025 -40.93%
2024 21.56%
2023 -47.33%
2022 -81.61%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.00 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 55.38%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $154.66 454.14%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $117.42 -19.34%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $753.28 8.59%
CH